|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 238.42 USD | -0.50% |
|
-4.26% | +14.92% |
| 05:01pm | Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment | MT |
| 04:46pm | Oil Shock Meets Job Shock |
Chart calendar Johnson & Johnson
Upcoming events on Johnson & Johnson
| 14/04/2026 | Earnings release - Q1 2026 | 13:45 |
| 14/04/2026 | Earnings presentation | 15:30 |
Past events on Johnson & Johnson
| 21/01/2026 | Earnings presentation | 16:30 |
| 21/01/2026 | Earnings release - Q4 2025 | Day |
| 14/10/2025 | Earnings presentation | 15:30 |
| 14/10/2025 | Earnings release - Q3 2025 | Day |
| 16/07/2025 | Earnings presentation | 15:30 |
| 16/07/2025 | Earnings release - Q2 2025 | 13:45 |
| 24/04/2025 | Annual General Meeting | 17:00 |
| 24/04/2025 | Présentation aux Actionnaires / Analystes | 17:00 |
| 15/04/2025 | Earnings presentation | 15:30 |
| 15/04/2025 | Earnings release - Q1 2025 | ~ 13:45 |
| 01/04/2025 | Information meeting | 15:00 |
Past dividends on Johnson & Johnson
| 24/02/2026 | Ex-dividend date - 1.3 USD | 08:00 |
| 25/11/2025 | Ex-dividend date - 1.3 USD | 08:00 |
| 26/08/2025 | Ex-dividend date - 1.3 USD | 07:00 |
| 27/05/2025 | Ex-dividend date - 1.3 USD | 07:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 85 159 84 764 0.47% | 88 821 88 765 0.06% | 94 193 93 759 0.46% | 100 616 | 106 127 | 112 631 |
|
EBITDA Million USD | Released Forecast Spread | 30 414 31 998 -4.95% | 29 288 30 409 -3.69% | 33 261 33 741 -1.42% | 36 932 | 39 361 | 42 298 |
|
EBIT Million USD | Released Forecast Spread | 27 460 27 881 -1.51% | 26 466 26 967 -1.86% | 30 358 30 751 -1.28% | 33 444 | 36 102 | 39 381 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 15 062 20 454 -26.36% | 16 687 20 759 -19.61% | 32 581 28 661 13.68% | 28 917 | 28 991 | 32 778 |
|
Net income Million USD | Released Forecast Spread | 35 153 19 696 78.48% | 14 066 17 495 -19.6% | 26 804 26 504 1.13% | 23 635 | 25 199 | 26 574 |
|
EPS USD | Released Forecast Spread | 13,7 8,44 62.56% | 5,79 6,93 -16.39% | 11,0 11,0 0.19% | 9,82 | 10,6 | 11,1 |
| Announcement Date | 23/01/24 | 22/01/25 | 21/01/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22 447 22 337 0.49% | 22 471 22 171 1.35% | 22 520 22 436 0.38% | 21 893 21 562 1.54% | 23 743 22 861 3.86% | 23 993 23 755 1% | 24 564 24 149 1.72% | 23 594 | 25 069 | 25 343 | 26 551 | 24 498 | 26 363 | 26 752 | 28 458 |
|
EBITDA Million USD | Released Forecast Spread | 8 388 8 129 3.18% | 7 164 7 063 1.43% | 5 763 6 223 -7.4% | 8 037 8 385 -4.15% | 8 637 8 279 4.32% | 8 897 8 583 3.65% | 7 685 8 086 -4.95% | 8 696 | 9 128 | 9 537 | 9 311 | 9 367 | 9 871 | 10 217 | 10 643 |
|
EBIT Million USD | Released Forecast Spread | 7 712 7 433 3.76% | 6 489 6 085 6.63% | 5 029 5 471 -8.08% | 7 385 7 290 1.31% | 7 961 7 605 4.68% | 8 168 7 998 2.13% | 6 844 7 196 -4.9% | 7 809 | 8 368 | 8 750 | 8 544 | 8 354 | 9 033 | 9 248 | 9 308 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 748 6 910 -16.82% | 3 338 4 923 -32.2% | 3 887 4 591 -15.33% | 13 631 5 447 150.25% | 6 491 6 600 -1.65% | 7 493 6 441 16.34% | 4 966 6 062 -18.08% | 6 671 | 7 282 | 7 571 | 7 438 | ||||
|
Net income Million USD | Released Forecast Spread | 4 686 5 093 -8% | 2 694 4 083 -34.02% | 3 431 4 240 -19.08% | 10 999 5 229 110.34% | 5 537 5 262 5.23% | 5 152 5 809 -11.3% | 5 116 5 515 -7.23% | 5 654 | 5 931 | 6 184 | 5 867 | ||||
|
EPS USD | Released Forecast Spread | 1,93 2,09 -7.72% | 1,11 1,69 -34.13% | 1,41 1,78 -20.69% | 4,54 2,26 100.92% | 2,29 2,18 5.05% | 2,12 2,29 -7.22% | 2,10 2,19 -4% | 2,27 | 2,50 | 2,58 | 2,42 | 2,47 | 2,74 | 2,77 | 2,70 |
| Announcement Date | 17/07/24 | 15/10/24 | 22/01/25 | 15/04/25 | 16/07/25 | 14/10/25 | 21/01/26 | - | - | - | - | - | - | - | - |
| 09/03/2026 | Information meeting | Day | |
| 09/03/2026 | Ex-dividend date - 0.12 USD | 07:00 | |
| 09/03/2026 | Ex-dividend date - 0.8 THB | 07:00 | |
| 09/03/2026 | Earnings release - Annual 2025 | 09:00 | |
| 09/03/2026 | Earnings presentation | 12:00 | |
| 09/03/2026 | Information meeting | 19:00 | |
| 10/03/2026 | Information meeting | Day | |
| 10/03/2026 | Ex-dividend date - 3.7 CHF | 07:00 | |
| 10/03/2026 | Extraordinary General Meeting | 09:00 | |
| 10/03/2026 | Annual General Meeting | 12:30 |
Past sector events for Johnson & Johnson
| Today | Annual General Meeting | 12:00 | |
| Today | Présentation aux Actionnaires / Analystes | 12:00 | |
| Today | Information meeting | 11:30 | |
| Today | Earnings presentation | 03:30 | |
| Today | Information meeting | Day | |
| 05/03/2026 | Earnings release - Annual 2025 | ~ 17:30 | |
| 05/03/2026 | Earnings presentation | 16:30 | |
| 05/03/2026 | Earnings presentation | 16:00 | |
| 05/03/2026 | Earnings presentation | 16:00 | |
| 05/03/2026 | Earnings release - Annual 2025 | 14:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
- Calendar Johnson & Johnson
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















